GenesisCare is recruiting patients with Dupuytren’s Disease for a research study called ‘DEPART’.
This study will assess patients with Dupuytren’s Disease in two settings: those who have early stages of the disease, and those who have progressive flexion contractures. It is the first trial of its kind and aims to assess safety and efficacy in the use of radiotherapy in both settings.
|Eligibility criteria|| |
To be considered for this study you must meet the following criteria:
|Study details|| |
This is a randomised study and your participation in this study would be approximately 5 years. Patients randomized to the treatment arm will receive 10 fractions of radiotherapy (treatment arm). Patients randomized to the observation arm will be followed up with their hand therapist as per standard of care. You will be required to attend clinic visit approximately every 6-12 months and be required to complete Quality of life questionnaires throughout the study.
|Further information|| |
For further information regarding this clinical trial click here.
|Get in touch|